Mazama Capital Management’s Gilead Sciences GILD Stock Holding History

Mazama Capital Management’s Portfolio GILD Stock Details GILD Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2016 Q1	–	Sell	-72,390	Closed	-$7.33M	–	64
2015 Q4	$7.33M	Sell	72,390 -1,347	-2%	-$140K	1.35%	21
2015 Q3	$7.24M	Buy	73,737 +17,314	+31%	+$1.92M	1.5%	16
2015 Q2	$6.61M	Buy	56,423 +1,287	+2%	+$141K	1.33%	16
2015 Q1	$5.41M	Buy	55,136 +5,906	+12%	+$600K	1.11%	24
2014 Q4	$4.64M	Buy	49,230 +12,888	+35%	+$1.33M	1.07%	26
2014 Q3	$3.87M	Sell	36,342 -9,548	-21%	-$935K	0.98%	28
2014 Q2	$3.8M	Buy	45,890 +15,200	+50%	+$1.18M	1.02%	33
2014 Q1	$2.17M	Sell	30,690 -4,838	-14%	-$379K	1.97%	18
2013 Q4	$2.67M	Sell	35,528 -7,949	-18%	-$553K	1.32%	12
2013 Q3	$2.73M	Buy	43,477 +7,954	+22%	+$475K	1.49%	10
2013 Q2	$1.82M	Buy	+35,523	New	+$1.85M	1.13%	31

Other funds holding GILD

Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return

Fidelity Investments Boston, Massachusetts $1.9T AUM 41.92% 1-Year Est. Return

State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return

BIT

BlackRock Institutional Trust San Francisco, California $675B AUM 16.07% 1-Year Est. Return

Capital Research Global Investors Los Angeles, California $645B AUM 30.41% 1-Year Est. Return

JP Morgan Chase New York $1.56T AUM 27.86% 1-Year Est. Return

T. Rowe Price Associates Baltimore, Maryland $865B AUM 30.76% 1-Year Est. Return

Bank of New York Mellon New York $544B AUM 28.31% 1-Year Est. Return

BFA

BlackRock Fund Advisors San Francisco, California $542B AUM 18.13% 1-Year Est. Return

Invesco Atlanta, Georgia $1.02T AUM 30.18% 1-Year Est. Return

Mazama Capital Management's GILD Position: Q1 2016 in Review

Mazama Capital Management sold out of Gilead Sciences (GILD) in Q1 2016, closing a stake of 72,390 shares — an estimated $7.33M sold.

Mazama Capital Management first reported a position in GILD in Q2 2013 and held it in 11 quarters. The position peaked at $7.33M in Q4 2015. 1,630 funds tracked by Wall St. Rank hold GILD as of Q1 2016.

Mazama Capital Management reported no remaining Gilead Sciences position as of Q1 2016 after selling out during the quarter.
Mazama Capital Management sold 72,390 Gilead Sciences shares in Q1 2016, an estimated $7.33M.
Mazama Capital Management first reported a position in Gilead Sciences in Q2 2013 and held it in 11 quarters.
Mazama Capital Management's Gilead Sciences position peaked at $7.33M in Q4 2015.
1,630 funds tracked by Wall St. Rank held Gilead Sciences as of Q1 2016.

Based on Mazama Capital Management's 13F filing for Q1 2016.